MedTrace Logo

Home Visitation Enhancing Linkages Project in Kansas

NCT06624332 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this study is to learn about whether digital screening and brief intervention can help address substance use in postpartum mothers who are enrolled in home visiting programs. The main questions it aims to answer are:

1. What combination of digital intervention components work best for postpartum mothers in home visiting programs?
2. What are the factors that help the intervention work best in home visiting, and what factors serve as barriers to the success of the intervention? Participants in the study will include home visiting staff and postpartum home visiting clients.

Participants who are home visitors will be asked to participate in focus groups and interviews, introduce the study to their clients and refer interested clients to the study, complete online surveys, and implement the home visitor components of the intervention with their clients who enroll in the study.

Participants who are home visiting clients will be asked to participate in focus groups and interviews, complete online surveys, and complete the digital screening and brief intervention sessions.

Conditions

  • Substance Use

Interventions

BEHAVIORAL

e-SBI main session

Single 20-minute e-SBI session that includes screening followed by brief motivational intervention.

BEHAVIORAL

e-SBI Booster Session

A 20-minute booster e-SBI session that reinforces content from the main e-SBI session.

BEHAVIORAL

Text messaging

4 weeks of daily automated text messages that reinforce content from the e-SBI main session.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • The National Center on Addiction and Substance Abuse at Columbia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-03-31
Completion
2027-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624332 on ClinicalTrials.gov